Prevalence of HIV Type 1 Antiretroviral Drug Resistance Mutations in Vietnam: A Multicenter Study

被引：22
|
作者：
Dean, Jonathan [2 ,3 ,4 ]
Thu Hong Ta Thi [1 ,2 ,3 ]
Dunford, Linda [2 ,3 ,4 ]
Carr, Michael J. [2 ,3 ,4 ]
Linh Thuy Nguyen [1 ,2 ,3 ]
Coughlan, Suzie [2 ,3 ,4 ]
Connell, Jeff [2 ,3 ,4 ]
Hien Tran Nguyen [1 ,2 ,3 ]
Hall, William W. [2 ,3 ,4 ]
Lan Anh Nguyen Thi [1 ,2 ,3 ]
机构：
[1] Natl Inst Hyg & Epidemiol, Lab Mol Diagnost, Hanoi, Vietnam
[2] Ireland Vietnam Blood Borne Virus Initiat IVVI, Dublin, Ireland
[3] Ireland Vietnam Blood Borne Virus Initiat IVVI, Hanoi, Vietnam
[4] Univ Coll Dublin, Natl Virus Reference Lab, Dublin 2, Ireland
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2011年 / 27卷 / 07期
关键词：
INTERNAL CONTROL; PCR ASSAY; PROVINCE; CHINA;
D O I：
10.1089/aid.2011.0013
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The prevalence of HIV-1 drug resistance mutations (DRMs) was determined for a cross-section of individuals (n = 8654) in five centers across Vietnam (Hanoi, Hai Phong, Da Nang, Khanh Hoa, and Can Tho) between 2008 and 2009. Following serological screening for HIV infection, HIV-1 viral load was determined, using an in-house real-time reverse transcriptase polymerase chain reaction (RT-PCR) assay. Samples with quantifiable viral loads [all either commercial sex workers (CSW) or intravenous drug users (IDU)] underwent DRM analysis. Sequences were obtained for 92 treatment-naive individuals, the majority of whom were infected with HIV-1 CRF01_AE (99%), with one instance of subtype A1 also detected. DRMs were detected in seven treatment-naive individuals (7.6%). The most common DRMs observed were M184V, V75A/M, M41L, and K65R (NRTI) and K103N, G190A, and Y181C (NNRTI). Overall, the data from this first multicenter survey of DRMs in Vietnam indicate that the problem of transmitted drug resistance is of major concern in the highest-risk groups of IDU and CSW.
引用
收藏
页码：797 / 801
页数：5
相关论文
共 50 条
  • [21] Nationwide Study of Drug Resistance Mutations in HIV-1 Infected Individuals under Antiretroviral Therapy in Brazil
    Santos-Pereira, Ana
    Triunfante, Vera
    Araujo, Pedro M. M.
    Martins, Joana
    Soares, Helena
    Poveda, Eva
    Souto, Bernardino
    Osorio, Nuno S.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
  • [22] Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection
    Booth, Clare L.
    Garcia-Diaz, Ana M.
    Youle, Michael S.
    Johnson, Margaret A.
    Phillips, Andrew
    Geretti, Anna Maria
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (03) : 517 - 524
  • [23] HIV-1 drug resistance in antiretroviral-naive individuals with HIV-1-associated tuberculous meningitis initiating antiretroviral therapy in Vietnam
    Thao, Vu P.
    Thuy Le
    Toeroek, Estee M.
    Yen, Nguyen T. B.
    Chau, Tran T. H.
    Jurriaans, Suzanne
    van Doorn, Rogier H.
    de Jong, Menno D.
    Farrar, Jeremy J.
    Dunstan, Sarah J.
    [J]. ANTIVIRAL THERAPY, 2012, 17 (05) : 905 - 913
  • [24] Low Prevalence of Transmitted HIV Type 1 Drug Resistance Among Antiretroviral-Naive Adults in a Rural HIV Clinic in Kenya
    Hassan, Amin S.
    Mwaringa, Shalton M.
    Obonyo, Clare A.
    Nabwera, Helen M.
    Sanders, Eduard J.
    de Wit, Tobias F. Rinke
    Cane, Patricia A.
    Berkley, James A.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (01) : 129 - 135
  • [25] Diversity and prevalence of antiretroviral genotypic resistance mutations among HIV-1-infected children
    Almeida, Flavia J.
    Berezin, Eitan N.
    Rodrigues, Rosangela
    Safadi, Marco A. P.
    Arnoni, Mariana V.
    Oliveira, Cristina
    Brigido, Luis F. M.
    [J]. JORNAL DE PEDIATRIA, 2009, 85 (02) : 104 - 109
  • [26] Prevalence of mutations related to HIV-1 antiretroviral resistance in Brazilian patients failing HAART
    Tanuri, A
    Caridea, E
    Dantas, MC
    Morgado, MG
    Mello, DLC
    Borges, S
    Tavares, M
    Ferreira, SB
    Santoro-Lopes, G
    Martins, CRF
    Esteves, ALC
    Diaz, RS
    Andreo, SMS
    Ferreira, LAP
    Rodrigues, R
    Reuter, T
    Cavalcanti, AMS
    de Oliveira, SM
    de Barbosa, HB
    Teixeira, PR
    Chequer, PN
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2002, 25 (01) : 39 - 46
  • [27] First Observation of HIV Type 1 Drug Resistance Mutations in Algeria
    Bouzeghoub, Salima
    Jauvin, Valerie
    Pinson, Patricia
    Schrive, Marie Helene
    Jeannot, Anne Cecile
    Amrane, Achour
    Masquelier, Bernard
    Belabbes, El Hadj
    Fleury, Herve J.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 (11) : 1467 - 1473
  • [28] HIV antiretroviral drug-resistance-associated mutations in New Zealand
    Schroeder, BA
    Croxson, MC
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2003, 28 : S77 - S77
  • [29] HIV-1 PREVALENCE AMONG DRUG DEATHS - A MULTICENTER STUDY
    LOCKEMANN, U
    PUSCHEL, K
    [J]. FORENSIC SCIENCE INTERNATIONAL, 1993, 62 (1-2) : 89 - 93
  • [30] Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort
    Machnowska, Patrycja
    Meixenberger, Karolin
    Schmidt, Daniel
    Jessen, Heiko
    Hillenbrand, Heribert
    Gunsenheimer-Bartmeyer, Barbara
    Hamouda, Osamah
    Kuecherer, Claudia
    Bannert, Norbert
    Knechten, H.
    Panstruga, P.
    Arasteh, K.
    Rittweger, M.
    Schuermann, M.
    Wesselmann, H.
    Moll, A.
    Bohr, U.
    Jessen, A. B.
    Schulbin, H.
    Schmidt, W.
    Karcher, H.
    Fischer, K.
    Schranz, D.
    Vallee, M.
    Claus, J. A.
    Thomas, C.
    Grimm, R.
    Klausen, G.
    Cordes, C.
    Brockmeyer, N. H.
    Potthoff, A.
    Roessler, S.
    Hower, M.
    Bachmann, C.
    Spornraft-Ragaller, P.
    Teichmann, D.
    Haeussinger, D.
    Jensen, B.
    Arbter, P. A.
    Haars, U.
    Esser, S.
    Schenk-Westkamp, P.
    Usadel, S.
    Mueller, M. C.
    Kreft, B.
    Lange, D.
    Polywka, S.
    Degen, O.
    Plettenbger, A.
    Kuhlendahl, F.
    [J]. PLOS ONE, 2019, 14 (01):
12345